DWF advises General Sales and Leasing, Inc. on the acquisition of Xenetic Biosciences plc

Top 20 law firm DWF has advised General Sales and Leasing, Inc. on its recommended offer for Xenetic Biosciences plc, a leading UK-based biopharmaceutical company, effected by a scheme of arrangement under Part 26 of the Companies Act 2006.

Under the offer General Sales and Leasing has acquired the entire issued and to be issued share capital of Xenetic and the deal has enabled Xenetic to implement its longer term strategy to expand into the biotechnology sector in the US.

Jay Birch, head of corporate in London, led the deal at DWF and commented: "A gap between the biotechnology sector in the UK and the US has been identified and this deal will enable Xenetic to expand into the US, where the sector is currently more advanced, facilitating its access to a quotation on a US stock market more easily."

Jay was supported on the deal by corporate director Manmohan Singh.

Jay Birch

Partner - Head of International Corporate Development

I am a Partner in the Corporate team and have extensive experience in the full range of corporate transactions.

Manmohan Singh


With over ten years' experience, Manmohan focuses his practice on international corporate matters, including corporate finance, mergers and acquisitions, and corporate investment.